Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03057457
Recruitment Status : Unknown
Verified March 2017 by BioPorto Diagnostics.
Recruitment status was:  Recruiting
First Posted : February 20, 2017
Last Update Posted : March 31, 2017
Sponsor:
Information provided by (Responsible Party):
BioPorto Diagnostics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : February 2018